Finance

Lists
IDIA:SWX
Idorsia Ltd
CHF 4.41
+1.80%
(+0.078) 1D
Nov 4, 5:31:16 PM GMT+1  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for IDIA...
Open
CHF 4.47
High
CHF 4.49
Low
CHF 4.27
Mkt. cap
1.19B
Avg. vol.
896.54K
Volume
853.24K
52-wk high
CHF 7.56
52-wk low
CHF 2.80
EPS
-CHF 1.45
Shares outstanding
269.80M
No. of employees
456
Open
CHF 4.47
High
CHF 4.49
Low
CHF 4.27
Mkt. cap
1.19B
Avg. vol.
896.54K
Volume
853.24K
52-wk high
CHF 7.56
52-wk low
CHF 2.80
EPS
-CHF 1.45
Shares outstanding
269.80M
No. of employees
456
News stories
From web sources and news partners
Profile
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
About Idorsia Ltd
CEO-
Employees456
Founded2017
Headquarters-
SectorBiotechnology
Industry-
Last report
Oct 29, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (CHF)
61.92M / 51.50M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
47.97M
57.39M
52.86M
61.92M
Cost of goods sold
36.94M
31.81M
37.73M
42.77M
Cost of revenue
36.94M
31.81M
37.73M
42.77M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.45M
51.46M
50.16M
53.46M
Operating expense
62.84M
52.11M
51.53M
54.94M
Total operating expenses
99.78M
83.92M
89.26M
97.72M
Operating income
-51.81M
-26.53M
-36.40M
-35.79M
Other non operating income
-31.45M
-451.00K
191.00K
-2.25M
EBT including unusual items
-75.91M
-46.18M
-105.97M
-52.39M
EBT excluding unusual items
-65.08M
-46.32M
-58.91M
-52.39M
Income tax expense
1.85M
-486.00K
1.08M
632.00K
Effective tax rate
-2.44%
1.05%
-1.02%
-1.21%
Other operating expenses
-2.19M
-653.00K
-53.00K
-11.00K
Net income
-77.76M
-45.70M
-107.05M
-53.02M
Net profit margin
-162.09%
-79.62%
-202.52%
-85.62%
Earnings per share
-
-
-
-
Interest and investment income
9.48M
-
50.00K
-
Interest expense
-
-19.35M
-21.65M
-15.45M
Net interest expenses
9.48M
-19.35M
-21.60M
-15.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
-47.78M
-22.77M
-32.53M
-32.06M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps